Ongoing randomized trials the gold standard for evaluating new uses of drugs are looking at the effects of GLP-1 drugs in early Alzheimers disease, with results expected later in 2025
WD is caused by mutations in ATP7B , which encodes a transmembrane copper-transporting ATPase, leading to impaired copper homeostasis and copper overload in the liver, brain and other organs
Unlike prior reports of fasting beyond 21 days in non-obese individuals [11, 12], this case demonstrates substantial weight loss (125 pounds) accompanied by improvements in depression, anemia, hypoxia/hypercapnia, functional status, and left ventricular (LV) mass
Recently, light-sensitive nanoparticles were synthesized utilizing DSPE-PEG to incorporate spiropyran under visible or dark conditions, indicating the potential for UV-Vis-activated drug release and tumor ablation (61)
Research on whether retatrutide causes muscle loss suggests that the same protein and resistance training strategies are needed across all GLP-1 class medications